Literature DB >> 21737541

Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection.

A Khawaldeh1, S Morales2, B Dillon1, Z Alavidze3, A N Ginn1, L Thomas1, S J Chapman1, A Dublanchet4, A Smithyman2, J R Iredell5,1.   

Abstract

We describe the success of adjunctive bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection in the context of bilateral ureteric stents and bladder ulceration, after repeated failure of antibiotics alone. No bacteriophage-resistant bacteria arose, and the kinetics of bacteriophage and bacteria in urine suggest self-sustaining and self-limiting infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737541     DOI: 10.1099/jmm.0.029744-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  42 in total

Review 1.  Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.

Authors:  Sabrina Royer; Aléxia Pinheiro Morais; Deivid William da Fonseca Batistão
Journal:  Arch Microbiol       Date:  2021-01-20       Impact factor: 2.552

2.  Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.

Authors:  Sharon S Y Leung; Thaigarajan Parumasivam; Fiona G Gao; Nicholas B Carrigy; Reinhard Vehring; Warren H Finlay; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Hak-Kim Chan
Journal:  Pharm Res       Date:  2016-02-29       Impact factor: 4.200

Review 3.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

Review 4.  Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory.

Authors:  Katherine M Caflisch; Robin Patel
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 5.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

6.  Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa.

Authors:  Abigail C Mapes; Barbara W Trautner; Kershena S Liao; Robert F Ramig
Journal:  Bacteriophage       Date:  2016-01-05

Review 7.  Bacteriophage Capsid Modification by Genetic and Chemical Methods.

Authors:  Caitlin M Carmody; Julie M Goddard; Sam R Nugen
Journal:  Bioconjug Chem       Date:  2021-03-04       Impact factor: 4.774

8.  Taking bacteriophage therapy seriously: a moral argument.

Authors:  Gilbert Verbeken; Isabelle Huys; Jean-Paul Pirnay; Serge Jennes; Nina Chanishvili; Jacques Scheres; Andrzej Górski; Daniel De Vos; Carl Ceulemans
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

9.  What are the limitations on the wider therapeutic use of phage?

Authors:  Alexandra Henein
Journal:  Bacteriophage       Date:  2013-04-01

10.  Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1.

Authors:  Alex Betts; Marie Vasse; Oliver Kaltz; Michael E Hochberg
Journal:  Evol Appl       Date:  2013-07-15       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.